(Q38504263)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26016407%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

review article

1 reference

title

The effect of antidepressants and antipsychotics on weight gain in children and adolescents (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26016407%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26016407%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

author name string

J Reekie

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26016407%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

S P M Hosking

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26016407%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

C Prakash

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26016407%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

K-T Kao

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26016407%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

M A Sabin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26016407%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

publication date

28 May 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26016407%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26016407%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26016407%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

page(s)

566-580

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26016407%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26016407%20AND%20SRC:MED&resulttype=core&format=json

Are child and adolescent mental health problems increasing in the 21st century? A systematic review.

15 February 2020

cites work

1 reference

Developments in pediatric psychopharmacology: focus on stimulants, antidepressants, and antipsychotics

21 January 2018

1 reference

Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents

21 January 2018

1 reference

Management of treatment-resistant depression in children and adolescents

21 January 2018

1 reference

Psychopharmacology of depression in children and adolescents

21 January 2018

1 reference

Serotonin controlling feeding and satiety

21 January 2018

1 reference

European Medicines Agency withdrawal for sibutramine

21 January 2018

1 reference

Management of schizophrenia in children and adolescents: focus on pharmacotherapy

21 January 2018

1 reference

Evidence-Based Health Policy---Lessons from the Global Burden of Disease Study

21 January 2018

1 reference

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

21 January 2018

1 reference

Weight gain and other metabolic adverse effects associated with atypical antipsychotic treatment of children and adolescents: a systematic review and meta-analysis

21 January 2018

1 reference

Prevalence and risk factors of overweight and obesity among children and adolescents with intellectual disabilities

21 January 2018

1 reference

Obesity and mental disorders in the general population: results from the world mental health surveys

21 January 2018

1 reference

A longitudinal evaluation of adolescent depression and adult obesity

21 January 2018

1 reference

Depressive symptoms in severely obese compared with normal weight adolescents: results from a community-based longitudinal study

21 January 2018

1 reference

Metabolic disturbances connecting obesity and depression.

21 January 2018

1 reference

Are children and adolescents with psychiatric illness at risk for increased future body weight? A systematic review.

21 January 2018

1 reference

Adolescent BMI trajectory and risk of diabetes versus coronary disease

21 January 2018

1 reference

Childhood adiposity, adult adiposity, and cardiovascular risk factors.

21 January 2018

1 reference

Characterisation of morbidity in a UK, hospital based, obesity clinic.

21 January 2018

1 reference

Predictors of changes in glucose tolerance status in obese youth

21 January 2018

1 reference

Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents

21 January 2018

1 reference

Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents

21 January 2018

1 reference

Safety of subchronic treatment with fluoxetine for major depressive disorder in children and adolescents

21 January 2018

1 reference

Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study

21 January 2018

1 reference

Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials

21 January 2018

1 reference

Escitalopram in the treatment of adolescent depression: a randomized placebo-controlled multisite trial.

21 January 2018

1 reference

Venlafaxine ER for the treatment of pediatric subjects with depression: results of two placebo-controlled trials

21 January 2018

1 reference

Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial

21 January 2018

1 reference

Fluoxetine in children and adolescents with OCD: a placebo-controlled trial

21 January 2018

1 reference

A prospective randomized double blind placebo controlled crossover study of fluoxetine efficacy in the prophylaxis of chronic daily headache in children and adolescents

21 January 2018

1 reference

SET-C versus fluoxetine in the treatment of childhood social phobia

21 January 2018

1 reference

Long-term sertraline treatment of children and adolescents with major depressive disorder.

21 January 2018

1 reference

SSRI Antidepressant Medications: Adverse Effects and Tolerability

21 January 2018

1 reference

Neuroendocrine-related adverse events associated with antidepressant treatment in children and adolescents.

21 January 2018

1 reference

Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial

21 January 2018

1 reference

Risperidone in the treatment of behavioral disturbances in children and adolescents with borderline intellectual functioning: a double-blind, placebo-controlled pilot trial

21 January 2018

1 reference

Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence

21 January 2018

1 reference

Risperidone in children with autism and serious behavioral problems

21 January 2018

1 reference

Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders

21 January 2018

1 reference

A randomized, double-blind, placebo-controlled study of risperidone maintenance treatment in children and adolescents with disruptive behavior disorders.

21 January 2018

1 reference

Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

A 6-week, randomized, double-blind, placebo-controlled study of the efficacy and safety of risperidone in adolescents with schizophrenia

21 January 2018

1 reference

Risperidone dosing in children and adolescents with autistic disorder: a double-blind, placebo-controlled study.

21 January 2018

1 reference

Risperidone associated weight, leptin, and anthropometric changes in children and adolescents with psychotic disorders in early treatment

21 January 2018

1 reference

Risperidone in children with disruptive behavior disorders and subaverage intelligence: a 1-year, open-label study of 504 patients

21 January 2018

1 reference

Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs.

21 January 2018

1 reference

Long-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation study

21 January 2018

1 reference

Efficacy, safety and tolerability of two dosing regimens in adolescent schizophrenia: double-blind study

21 January 2018

1 reference

A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia

21 January 2018

1 reference

A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder

21 January 2018

1 reference

Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder

21 January 2018

1 reference

A double-blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorder.

21 January 2018

1 reference

Olanzapine versus placebo in the treatment of adolescents with bipolar mania.

21 January 2018

1 reference

Olanzapine versus placebo in adolescents with schizophrenia: a 6-week, randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

Comparison of open-label, 8-week trials of olanzapine monotherapy and topiramate augmentation of olanzapine for the treatment of pediatric bipolar disorder

21 January 2018

1 reference

Update on obesity pharmacotherapy

21 January 2018

1 reference

A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents.

21 January 2018

1 reference

Childhood-onset schizophrenia: A double-blind, randomized clozapine-olanzapine comparison.

21 January 2018

1 reference

A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder

21 January 2018

1 reference

Efficacy and safety of quetiapine in adolescents with schizophrenia investigated in a 6-week, double-blind, placebo-controlled trial.

21 January 2018

1 reference

A prospective 12-week study of quetiapine in adolescents with schizophrenia spectrum disorders

21 January 2018

1 reference

Olanzapine compared to quetiapine in adolescents with a first psychotic episode

21 January 2018

1 reference

Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study

21 January 2018

1 reference

A Pilot Study of Risperidone, Olanzapine, and Haloperidol in Psychotic Youth: A Double-Blind, Randomized, 8-Week Trial

21 January 2018

1 reference

Risperidone versus haloperidol in children and adolescents with AD : a randomized, controlled, double-blind trial

21 January 2018

1 reference

Tic reduction with risperidone versus pimozide in a randomized, double-blind, crossover trial

21 January 2018

1 reference

A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents

21 January 2018

1 reference

Double-blind randomized trial of risperidone versus divalproex in pediatric bipolar disorder

21 January 2018

1 reference

How training affects Australian paediatricians' management of obesity

21 January 2018

1 reference

Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors

21 January 2018

1 reference

Long-term persistence of hormonal adaptations to weight loss.

21 January 2018

1 reference

Set-point theory and obesity

21 January 2018

1 reference

A randomized, triple masked, placebo-controlled clinical trial for controlling childhood obesity.

21 January 2018

1 reference

The role of thermogenesis in antipsychotic drug-induced weight gain.

21 January 2018

1 reference

Adolescent Obesity and Risk for Subsequent Major Depressive Disorder and Anxiety Disorder: Prospective Evidence

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/OBR.12284

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26016407%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference